ecopipam has been researched along with 3,4-dihydroxyphenylacetic acid in 2 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (3,4-dihydroxyphenylacetic acid) | Trials (3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 5,410 | 38 | 591 |
| Protein | Taxonomy | ecopipam (IC50) | 3,4-dihydroxyphenylacetic acid (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 4.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, A; Berger, JG; Chipkin, RE; Coffin, VL; Iorio, LC; McQuade, RD | 1 |
| Emmi, A; Rajabi, H; Stewart, J | 1 |
2 other study(ies) available for ecopipam and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzazepines; Catalepsy; Dogs; Dopamine; Dopamine Antagonists; Homovanillic Acid; Male; Mice; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Vomiting | 1988 |
Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Male; Microdialysis; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D5; Substantia Nigra; Sympatholytics | 1997 |